Home » Negotiating With Firms Improves Drug Labels, Gottlieb Says
Negotiating With Firms Improves Drug Labels, Gottlieb Says
August 26, 2005
Lawmakers returning from summer recess are expected to renew their push for FDA drug-safety reforms, including measures that would give the agency the authority to mandate drug labeling changes. But one top agency official argues that drug sponsors play an essential role in crafting the most comprehensive labeling possible.